US FDA staff flags concerns on MDMA-assisted PTSD treatment

- The U.S. health regulator's staff reviewers on Friday raised concerns related to interpretation of results from trials for Lykos Therapeutics' psychedelic drug MDMA to treat post-traumatic stress disorder.

A panel of outside advisers to the U.S. Food and Drug Administration will meet on Tuesday to review for the first time a form of MDMA.The agency has so far never approved the therapeutic use of the mind-altering drug, commonly called ecstasy or molly.It has been our privilege to have the trust and support of our East Coast communities for the last 200 years. Our SaltWire team is always watching out for the place we call home.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

US FDA panel to discuss first psychedelic-assisted PTSD treatment next monthExplore stories from Atlantic Canada.
Source: SaltWire Network - 🏆 45. / 63 Read more »

Investors Warm Up to Psychedelics as FDA Reviews Treatment for PTSDCompanies developing psychedelic drugs are no longer seen as niche investments with key regulatory decisions on the horizon.
Source: BNNBloomberg - 🏆 83. / 50 Read more »

This Instagram Account Posts Hilarious Memes About Mental Health, Here Are The 51 Best OnesThe “PTSD.eezenuts” Instagram page shares hilarious and relatable mental health and therapy memes.
Source: boredpanda - 🏆 18. / 72 Read more »